Serac Life Sciences

Our CEO Mark Rosser enjoyed updating journalist Shani Alexander from Bioworld Medtech recently about the ongoing clinical studies using Seracam at three international sites where encouraging results are being reported from studies in small organ imaging and sentinel lymph node biopsy. Subscribers can read the full article behind the paywall here: https://lnkd.in/gYfwMh6X Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #gammacamera #nuclearmedicine #hybridimaging #pointofcareimaging #thyroidimaging #smallorganimaging #breastcancer #sentinellymphnodebiopsy Clarivate for Life Sciences & Healthcare

We are excited to report that an abstract on preliminary data from our DETECT imaging study has been accepted as a Top Rated Oral Presentation at the annual congress of the European Association of Nuclear Medicine (EANM) taking place from 18-23 October 2024 in Hamburg, Germany. The DETECT study is evaluating the potential of maraciclatide to visualise endometriosis, and specifically superficial peritoneal endometriosis, which could have a significant impact on the lives of millions of women suffering with the disease. The study is ongoing and the presentation will include the latest findings and insights into the detection of disease subtypes. Many thanks to authors Munir Ghesani MD, FACNM, FACR, FSNMMI Jon Barnett Tatjana Gibbons Druin Burch; S Cade and R Graham (Royal United Hospitals Bath NHS Foundation Trust); N Patel (John Radcliffe Hospital, Oxford); Krina Zondervan and C Becker (Nuffield Dept of Women's & Reproductive Health, University of Oxford and EndoCaRe Oxford 🎗️ ). Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine

Seracam’s performance characterisation results have been published for the first time by our academic partners at Loughborough University: “The results of this work clearly demonstrate that for SFOV [small field of view] imaging, Seracam offers the potential to extend the utility of nuclear medicine investigations beyond the restraints of the larger fixed camera systems.” Congratulations to Sarah Bugby and the team on this important publication. The open access article is available here: https://lnkd.in/eNPgeUC7 Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #medicalimaging #diagnosticimaging #gammaimaging #hybridimaging #nuclearmedicine #molecularimaging

We are excited to report major news this week for the development of ⁹⁹ᵐTc-maraciclatide as an imaging agent for endometriosis: the US Food & Drug Administration (FDA) has granted fast track designation to maraciclatide "for the visualisation and diagnosis of superficial peritoneal endometriosis in women 16 years of age or older". Fast track is a process designed to facilitate the development and expedite the review of drugs to treat (or in our case, diagnose) serious conditions and fill an unmet medical need so that patients can benefit sooner. Superficial peritoneal endometriosis (SPE) is the earliest and most common form of endometriosis, comprising approximately 80% of all diagnoses. SPE is not well visualised with current non-invasive imaging tools (ultrasound and MRI) and definitive diagnosis requires laparoscopy. In data previously reported from the DETECT study being run by our colleagues at the Nuffield Dept of Women's & Reproductive Health, University of Oxford, maraciclatide correctly identified superficial peritoneal endometriosis in those who went on to have this early-stage endometriosis confirmed by laparoscopy. Please see full details here: https://lnkd.in/eQM3nCKm Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. #FDAFastTrack #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine EndoCaRe Oxford 🎗️ Spectrum Dynamics Medical Hermes Medical Solutions Krina Zondervan Tatjana Gibbons

We have received great news from our clinical partners running studies using Seracam at the University of Malaya Medical Centre. Dr Aik Hao Ng and his team are reporting encouraging early results using Seracam and have had abstracts accepted on the clinical evaluation of scans using the camera in both small organ imaging and image guided surgery at two prestigious meetings this autumn. Please see more details here: https://lnkd.in/eqMRd3_t Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. European Association of Nuclear Medicine (EANM) International Atomic Energy Agency (IAEA) #nuclearmedicine #hybridimaging #pointofcareimaging #thyroidimaging #smallorganimaging #breastcancer #sentinellymphnodebiopsy  

Great to see our DETECT study covered earlier this month in PharmaTimes here: https://lnkd.in/dpUrYGnV #womenshealth #molecularimaging #medicalimaging #endometriosis #precisionmedicine #nuclearmedicine Nuffield Dept of Women's & Reproductive Health, University of Oxford Tatjana Gibbons Krina Zondervan

It is a priviledge to be part of the SERACAM project and conducted the first use SERACAM in the sentinel node localization procedure in breast cancer surgery at #UMMC. Due to the big size of standard gamma camera, our team have been working hard and dreamed to bring this camera into the operating theatre for intra-operative imaging. 6 June 2024 marked an important milestone where we managed to perform the first use of SERACAM in the OT for breast cancer surgery. There is a dream, there is a hope❤️ #medicineum #fomum #ServingTheNation #ImpactingTheWorld #homeofthebright #landofthebrave

Continuing positive results from the DETECT study comparing the imaging of superficial peritoneal endometriosis by ⁹⁹ᵐTc-maraciclatide with laparoscopic surgery are being presented today in a poster by one of the investigators, Dr Tatjana Gibbons from the Nuffield Dept of Women's & Reproductive Health, University of Oxford. The poster will be on display at the 7th European Endometriosis Congress taking place in Bucharest from 6-8 June. For full details, please see the press release here https://lnkd.in/eC42HGhV #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EEC2024 European Endometriosis League Spectrum Dynamics Medical Hermes Medical Solutions Krina Zondervan Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.